Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-056994
Filing Date
2026-02-18
Accepted
2026-02-18 16:01:02
Documents
1
Period of Report
2026-02-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3543
  Complete submission text file 0001193125-26-056994.txt   5257
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CARA THERAPEUTICS, INC. 4 STAMFORD PLAZA, 107 ELM STREET STAMFORD CT 06902
Business Address
Mohindru Mani (Reporting) CIK: 0001664708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 26648058